| 
PREIMPLANTATION GENETIC TESTING:
UNDIVINE INTERVENTION?
“Do we want to have a society where parents can
flip through a DNA catalogue and design their own ‘boutique
baby’? Will we accept that it is perfectly reasonable
to discriminate against people before they are born, or
prevent them from being born, because we don’t like
their genes?” Dean Hamer, Geneticist at the National
Cancer Institute from “Remaking Eden” by Dr.
Lee M. Silver.
By: Dean E. Masserman, Esq.
Until recently, genetic disorders could
only be detected during pregnancy using one of two methods:
amniocentesis and chorionic villus sampling. Amniocentesis
is done when the fetus is twelve to sixteen weeks old and
consists of drawing a sample of the amniotic fluid from
around the fetus and examining a floating cell from the
fetus. Chorionic Villus sampling involves taking a small
sample of the placenta at an early stage of development
and examining it in the laboratory. The problem with these
two procedures is that they can only be performed after
conception, and after significant fetal development. Therefore,
if the analysis shows that the fetus is genetically defective,
the parents are faced with a decision of whether or not
to terminate the pregnancy.
However, thanks to recent advances in genetics,
an alternative procedure now exists which enables geneticists
to diagnose most genetic defects in the embryonic stage,
before pregnancy is established. This technique would vitiate
the need for screening during the pregnancy and hence prevent
the psychological trauma associated with terminating a pregnancy
where genetic defects are detected. Moreover, it will enable
couples who are carriers of profound genetic disorders to
significantly decrease the risk of having a child that is
afflicted with the same problems. For these couples, this
technology is a miracle that will enable them to create
a healthy family. To the majority though, the consequences
of such intervention is daunting as it raises issues of
sex selection and genetic engineering. Preimplantation Genetic
Diagnosis (PGD), is a recently developed technique that
can be utilized during In Vitro Fertilization (IVF) procedures
to test embryos for various genetic disorders prior to an
intrauterine transfer. PGD was made possible by the advent
of a process called polymerase chain reaction (PCR) which
allows a specific DNA sequence to be replicated many times
and then rapidly analyzed.
The advent of PCR has been characterized
as the most important scientific discovery of the twentieth
century; completely changing the course of the biological
and biomedical sciences. In the field of third party reproduction
the effects of these advances are profound, and the procedures
quite simple.
Embryos are obtained by combining an egg
and a sperm in a petri dish under laboratory conditions.
(IVF). As each embryo divides to about the 8 cell level
it is isolated and a blastomere (single cell) is removed
from each embryo and tested for the presence of genetic
disorders; the entire process taking only 12-24 hours. Those
that display some type of genetic abnormality are disposed
of and the unaffected embryos are transferred back into
the uterus in the IVF cycle. This highly sophisticated technique
called micro- manipulation does not adversely affect further
development of the embryo and has already produced more
than thirty pregnancies worldwide. More importantly, it
has been scientifically shown to effectively detect a wide
variety of genetic diseases including cystic fibrosis, Tay-Sachs,
Duchenne muscular dystrophy, hemophilia, fragile X-syndrome,
retinitis pigmentosa, Lesch-Nyhan syndrome, Charcot Marie
tooth disease, gender down syndrome, Marfan syndrome, spinal
muscular atrophy (SMA), and could be employed to detect
nearly 200 other gender related genetic disorders.
So where is the dilemma? PGD is simple,
non-intrusive, relatively cost efficient and extraordinarily
accurate. PGD avoids the stress and emotional trauma of
having to terminate a pregnancy and enables couples to have
a child with the full assurance that it will not be carrying
any genetic disease passed on by them. Simply put, it allows
parents to manipulate the process of natural selection and
therein lies the rub. The dilemma facing geneticists, and
soon the world at large, is whether or not such intervention
is moral, and to what extent the practice should be utilized.
The technology has much broader application than that discussed
thus far. Prospective parents can not only screen for genetic
defects, but potentially could determine the entire genetic
makeup of the their unborn child. They may opt for a more
artistic female child with fair skin and blonde hair. They
may want a male child who is more analytical and has a passion
for sports. Or, they may simply use PGD as a sex selection
tool. And some couples may try to screen out the DNA alleles
that account for obesity, high blood pressure and acne.
Additionally there are the fundamental
religious considerations. Some might consider this procedure
murder because the cell that is removed could have conceivably
developed into a fetus, but instead it was destroyed as
part of the testing. Others might contend that a genetically
fertilized egg, if allowed to mature and result in a live
birth, may not produce a defect at all, or may not manifest
any symptoms until the person is in his/her early thirties
or forties by which time a cure could be developed.
These illustrations, albeit extreme, do
serve to make a point. PGD may take us down a road that
will rapidly transform to a slippery slope. Currently, only
a handful of specialized institutions with excellent IVF
and molecular biology laboratories offer preimplantation
diagnosis, and only to those couples at high risk, or those
who have already had an affected child. However, with the
coming of the new millennium, so comes a plethora of legal,
ethical and moral quandaries that will literally shape our
children and the world they live in.
[ Return to Journal of Assisted Reproductive Law ]
|